Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04031924
Other study ID # NACIYEVARDAR
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 20, 2017
Est. completion date October 20, 2018

Study information

Verified date July 2019
Source Hacettepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

Kinesiophobia and Physical Fitness, and Related Factors in Liver Transplantation


Recruitment information / eligibility

Status Completed
Enrollment 32
Est. completion date October 20, 2018
Est. primary completion date July 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria:

- All patients older than 18 years of age who had undergone liver transplantation at Hacettepe University Hospital at least one year ago were eligible for the study.

Exclusion Criteria:

- Hepatic encephalopathy

- Progressive cardiac and/or pulmonary disease

- Central nervous system pathologies

- Orthopedic problems preventing physical assessments

- Multiorgan transplantation

- Cognitive deficits

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Assessment of: 1. Functional Capacity 2. Physical Fitness 3. Physical Activity Level 4. Balance 5. Kinesiophobia 6. Psychological Status 7. Fatigue Severity
All liver transplantation patients who underwent transplant at least one year ago and healthy subjects were evaluated the first day they came.

Locations

Country Name City State
Turkey Hacettepe University Ankara

Sponsors (1)

Lead Sponsor Collaborator
Hacettepe University

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Physical Fitness The Chair Stand Test: This requires people to repeatedly stand up from and sit down on a chair for 30 seconds. The number of stands is recorded. 10 minutes
Primary Physical Fitness The Biceps Curl Test: This requires people to repeatedly lift a 5 lb(2.27 kg) weight (for women) or an 8 lb (3.63 kg) weight (for men) for 30 seconds. The number of lifts is recorded. 10 minutes
Primary Physical Fitness The 6-minute Walk Test: This is measured in distance (m) and reflects aerobic endurance. The original version of the Senior Fitness Test required people to walk on a straight line. 30 minutes
Primary Physical Fitness The Chair Sit and Reach Test: This is measured in distance (cm) and reflects lower body flexibility. 5 minutes
Primary Physical Fitness The Back Scratch Test: This is measured in distance (cm) and reflects upper body flexibility. 5 minutes
Primary Physical Fitness The 8-Foot Up-and-Go test: This is measured in time (seconds) and reflects agility and dynamic balance. 10 minutes
Secondary Kinesiophobia Kinesiophobia was assessed in all participants using the Tampa Scale of Kinesiophobia (TSK). The TSK is a self-completed questionnaire and the range of scores are from 17 to 68 where the higher scores indicate an increasing degree of kinesiophobia. 15 minutes
Secondary Balance Berg Balance Scale (BBS) was used to evaluate balance. The BBS consists of 14 items which include simple mobility task and that are scored on a scale of 0 to 4. The level of proficiency for each activity, a score of "0" is given if the participant is unable to do the task and a score of "4" is given if the participant can complete the task based on the criterion that has been assigned to it. The maximum total score on the test is 56. 20 minutes
Secondary Balance The Timed Up and Go Test was used to assess the balance performance of people during the movement. For the starter position, a participant sits in a chair with standard height, measuring a distance of 3 meters from the chair. The test timer starts by the clinician at the moment the clinician said "go", the participant gets up from a chair, walks 3 meters, turns 180° a designed spot, walks back to the seat, when the participant sits down then the test stopped. 15 minutes
See also
  Status Clinical Trial Phase
Completed NCT03234218 - Vitamin D Levels in Liver Transplantation Recipients Prospective Observational Study
Completed NCT04546048 - The Early Strength Training Program in Post-transplant Liver Cases N/A
Completed NCT05625139 - Implementation of an Enhanced Rehabilitation Protocol After Liver Transplantation: Feasibility and Analysis of Results
Not yet recruiting NCT06014320 - Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
Recruiting NCT05537948 - Efficacy and Safety of Pitavastatin and PCSK9 Inhibitors in Liver Transplant Patients Phase 4
Recruiting NCT05107271 - Evaluation of Long Haul COVID-19 and Vaccine Immunogenicity in Patients With Liver Disease
Completed NCT03775863 - AFP Model and Liver Transplantation.
Recruiting NCT04570969 - Benefit of ESP Peri Operative Analgesia for Live Liver Donor Transplantation N/A
Terminated NCT04584151 - Perioperative Analgesia by ESP Catheter on Recipient for Liver Transplantation N/A
Completed NCT05378451 - Totally Extraperitoneal Repair of Groin Hernia in Liver Transplanted Patients
Not yet recruiting NCT04825470 - Liver Transplantation for Unresectable GIST Liver Metastases N/A
Completed NCT02543151 - SpyGlass in Post Liver Transplant Biliary Complications. N/A
Enrolling by invitation NCT05082077 - Global Utilization And Registry Database for Improved preservAtion of doNor Livers
Recruiting NCT05761483 - Endoscopic Management of Non-anastomotic Biliary Strictures Following Liver Transplantation.
Terminated NCT04316468 - Cardiac Strain Using Speckle Tracking Echocardiography During Orthotopic Liver Transplantation
Completed NCT04576572 - Comparison of Criteria for Liver Transplantation in Hepatocellular Carcinoma
Not yet recruiting NCT06455280 - SIPLIZUMAB in AILD and LT Phase 1
Terminated NCT04838314 - Perioperative Analgesia by ESP Catheter on Paediatric Recipient for Liver Transplantation N/A
Completed NCT04111146 - Effect of 25-OH-vitamin D3 on the Liver Transplant Recipients
Completed NCT05200195 - Deep Learning Model for the Prediction of Post-LT HCC Recurrence